Candel Therapeutics Inc (CADL) stock news · rev $125.0K
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
This CADL news page leads with what Candel Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CADL yet. We will not pad this page with generic market recap.
Latest reported CADL revenue for 2022-12-31 was $125.0K. Net income was -$18.8M. CADL currently screens at market cap $592.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CADL stock page; for the tape open the quote page.
CADL stock news FAQ
What are CADL's latest revenue and net income?
Latest cached Candel Therapeutics Inc (CADL) revenue for Dec 31, 2022 was $125.0K. Net income was -$18.8M. Statements: https://lician.com/financials/cadl
What is CADL's market cap?
Candel Therapeutics Inc (CADL) market cap is $592.0M on the latest cached fundamentals snapshot.
What kind of company is CADL?
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Where is CADL stock news listed?
Cached stock news for Candel Therapeutics Inc (CADL) is listed at https://lician.com/news/cadl. Filings: https://lician.com/sec/cadl
Not investment advice.